A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease (Q53239126)
scientific article published in January 2000
Language:
(P31) (Q13442814)
(P304) 236-241
(P407) (Q1860)
(P433) 4
(P478) 44
(P577) Saturday, January 1, 2000
(P921) (Q181600)
(P1104) 6
(P1433) (Q1376833)
(P1476) "A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease" (language: en)
(P2093) M Farlow
R Anand
J Messina
R Hartman
J Veach
other details
aliases A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease
description scientific article published in January 2000

External Links